Skip to content

Exploratory Investigation on a Novel Catheter

Exploratory Investigation on a Novel Catheter - NAV-0010

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON53534
Enrollment
15
Registered
2022-10-06
Start date
2022-11-29
Completion date
Unknown
Last updated
2024-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bowel dysfunction Transanal irrigation

Interventions

The Bulb Catheter will be inserted into the anus and anal canal as a part of the TAI procedure. One Bulb catheter of each size used at two different occasions are considered enough to evaluate the B

Sponsors

Wellspect HealthCare
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Provision of informed consent. 2. Female and male aged 18 - 80 years. 3. Patients successfully treated by TAI with Navina Smart system for at least 3 months and/or stable in therapy. 4. Able to read, write and understand information given to them regarding the study.

Exclusion criteria

Exclusion criteria: 1. Involvement in the planning and conduct of the clinical investigation (applies to both Wellspect HealthCare staff and staff at the study site). 2. Previous enrolment in the present clinical investigation. 3. Simultaneous participation in another clinical investigation, or participation in a clinical investigation during the last month, that may interfere with the present clinical investigation. 4. Severe non-compliance to Clinical Investigation Plan as judged by the investigator and/or Wellspect HealthCare. 5. Significant cardiovascular and/or other significant co-morbidities which could be negatively affected by the use of the investigational product. 6. Known anal or colorectal stenosis. 7. Active inflammatory bowel disease. 8. Acute diverticulitis. 9. Colorectal cancer. 10. Ischemic colitis. 11. Any anal or colorectal surgery within the previous 3 months. 12. Anal, rectal and/or colonic endoscopic polypectomy within the previous 4 weeks. 13. Any condition, as judged by the investigator, which might make follow-up or investigations inappropriate. 14. Any patient that according to the Declaration of Helsinki is unsuitable for enrolment.

Design outcomes

Primary

MeasureTime frame
Primary endpoint: Yes / No confirmation if catheter stay in place during water instillation by assessment of expulsion of catheter.

Secondary

MeasureTime frame
Secondary endpoint: Emptying of bowel similar to regular use of Navina Smart system & Leakage similar to regular use of Navina Smart system.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)